Share Prices & Company Research

Stockbroking

Vectura Group

Current Price 73.33p Bid 72.00p Ask 72.25p Change -4.18%
Last Updated: 24/02/2018 16:02. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

Vectura Group plc is an industry-leading device and formulation business for inhaled airways products offering a uniquely integrated inhaled drug delivery platform. With its extensive range of device and formulation technologies, integrated capabilities and collaborations, it is a leader in the development of inhalation products, increasing its ability to help patients suffering from respiratory diseases. Vectura has eight inhaled, four non-inhaled and ten oral products marketed by partners with growing global royalty streams. The Group has a diverse portfolio of drugs in clinical development, including a number of novel and generic programmes which are partnered with several global pharmaceutical and biotechnology companies including Hikma, Novartis, Sandoz, Mundipharma, Kyorin, Baxter, GSK, UCB, Ablynx, Grifols, Bayer, Chiesi, Almirall, Janssen, Dynavax and Tianjin KingYork along with two wholly owned nebulised development.

Financial Highlights Year Ended 31/12/2016

Turnover
£126.50m
Operating Profit
£-44.50m
Dividend Yield
0.00
Dividend Per Share
0.00
Dividend Cover
0.00
P/E Ratio
-14.02

Key Personnel

James Ward-Lilley
Chief Executive Officer
Mehul Andrew Derodra
Chief Financial Officer
Bruno Francois Jules Angelici
Non-Executive Chairman
Frank Charles Condella
Non-Executive Dep Chairman
Juliet Thompson
Non-Executive Director
Dr Thomas Werner
Non-Executive Director
Dr Per-Olof Andersson
Non-Executive Director
Dr Susan Elizabeth Foden
Non-Executive Director
Neil William Warner
Non-Executive Director

Stock Details

EPIC
VEC
ISIN
GB00B01D1K48
Shares in Issue
665,776,109
Market cap
£494.67m

Analyst Views (6)

Strong Buy
 
66.67%
Buy
 
0.00%
Hold
 
33.33%
Sell
 
0.00%
Strong Sell
 
0.00%
The above information represents a selection of the views published in the last 120 days by analysts. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
72.25p
Bid Price
72.00p
Ask Price
72.25p
Volume
6066717
Change Today
-3.15p
% Change Today
-4.18%
Open
75.30p
Previous Close
72.25p
Intraday High
76.45p
Intraday Low
70.15p
52 Week High
166.90p
52 Week Low
70.50p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

Vectura Group Intra-day Chart

Vectura Group News

News in this section is provided by MoneyAM

Director Deals - Vectura Group PLC (VEC) 15 Feb 2018 | 11:45 Broker Forecast - Peel Hunt issues a broker note on Vectura Group PLC 14 Feb 2018 | 09:10 Director Deals - Vectura Group PLC (VEC) 18 Jan 2018 | 11:45 Broker Forecast - JP Morgan Cazenove issues a broker note on Vectura Group PLC 05 Jan 2018 | 11:20 Vectura revenues in line 04 Jan 2018 | 08:15 Market report: FTSE in positive end of year mood 29 Dec 2017 | 09:05 FTSE grinds to a halt amid lack of large cap news 28 Dec 2017 | 16:39 Broker Forecast - RBC Capital Markets issues a broker note on Vectura Group PLC 14 Dec 2017 | 12:00 Director Deals - Vectura Group PLC (VEC) 12 Dec 2017 | 15:55 Vectura Group appoints new director 29 Nov 2017 | 07:44 Vectura comments on Ultibro 27 Nov 2017 | 13:36 Broker Forecast - JP Morgan Cazenove issues a broker note on Vectura Group PLC 10 Nov 2017 | 09:50 Director Deals - Vectura Group PLC (VEC) 09 Nov 2017 | 14:50 Broker Forecast - Numis issues a broker note on Vectura Group PLC 09 Nov 2017 | 12:50 Vectura Group boosts 3Q sales 24 Oct 2017 | 07:44 Vectura licencee launches Seebri Neohaler in the US 19 Oct 2017 | 14:25 Director Deals - Vectura Group PLC (VEC) 10 Oct 2017 | 11:35 Vectura EBT buys shares in VEC 04 Oct 2017 | 14:05 Broker Forecast - JP Morgan Cazenove issues a broker note on Vectura Group PLC 21 Sep 2017 | 08:40 Director Deals - Vectura Group PLC (VEC) 13 Sep 2017 | 10:15 Director Deals - Vectura Group PLC (VEC) 12 Sep 2017 | 10:05 Director Deals - Vectura Group PLC (VEC) 08 Sep 2017 | 14:40 Director Deals - Vectura Group PLC (VEC) 08 Sep 2017 | 09:55 Broker Forecast - Numis issues a broker note on Vectura Group PLC 07 Sep 2017 | 10:40 Vectura progresses with the development of VR410 for US market 06 Sep 2017 | 07:52 Vectura revenues jump 6.6% 06 Sep 2017 | 07:47 Vectura signs exclusive agreement with Dynavax 16 Aug 2017 | 08:04 FLASH: Vectura signs smart nebuliser agreement 16 Aug 2017 | 07:17 Director Deals - Vectura Group PLC (VEC) 07 Aug 2017 | 14:20 Director Deals - Vectura Group PLC (VEC) 10 Jul 2017 | 16:25

Assets (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2016
31 Mar 2016
Tangible Assets
54.8
11.6
Intangible Assets & Goodwill
619.6
149.6
Investments & Other Non-Current Assets
4.0
1.6
Total Non-Current Assets
678.4
162.8
Inventory
18.4
0.7
Trade & Receivables
56.6
22.2
Cash & Receivables
92.5
99.8
Other Current Assets & Assets Held for Resale
0.0
0.3
Total Assets
845.9
285.8

Liabilities (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2016
31 Mar 2016
Short Term Liabilities
70.3
27.2
Long Term Liabilities
98.4
21.4
Other Liabilities / Pension etc
0.0
0.0
Total Liabilities
168.7
48.6

Net Assets (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2016
31 Mar 2016
Net Assets
677.2
237.2

Equity (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2016
31 Mar 2016
Share Capital
0.2
0.1
Minority Interests
0.0
0.0
Retained Earnings
-23.7
-7.4
Share Premium Account
102.3
101.6
Other Equity
598.4
142.9
Total Equity
677.2
237.2

Cashflow (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2016
31 Mar 2016
Cashflow from Operating Activities
28.2
32.9
Cashflow Before Financing
18.3
7.4
Increase / Decrease in Cash
-7.3
9.8

Income (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2016
31 Mar 2016
Turnover
126.5
72.0
Cost of Sales
41.9
3.3
Gross Profit
84.6
68.7
Operating Profit
-44.5
-5.1
Pre-Tax Profit
-40.1
-1.9
Profit / Loss for the Year
-32.1
5.0
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.